Trial Profile

Phase II trial of WP-1220 as a topical therapy for Cutaneous-T-cell-lymphoma (CTCL)

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 05 Jul 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs WP 1220 (Primary)
Indications Cutaneous T-cell lymphoma
Focus Therapeutic Use

Most Recent Events

24 Mar 2021 According to a Moleculin Biotech media release, the company plans to seek a collaborative partner to support a Phase 2 clinical study of WP1220 in CTCL in 2021.
19 Mar 2020 According to a Moleculin Biotech media release, the company plans a Pre-IND Meeting with FDA/EMA and file a IND/CTA concerning this Phase 2 clinical trial with WP1220 for the treatment of CTCL in 2020.
20 Feb 2020 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com